ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 955 filers reported holding ISHARES TR in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,407,274 | -7.9% | 11,493 | -4.5% | 0.04% | +11.8% |
| Q2 2023 | $1,527,357 | -8.3% | 12,030 | -6.7% | 0.03% | -22.7% |
| Q1 2023 | $1,665,638 | -12.7% | 12,896 | -11.3% | 0.04% | -17.0% |
| Q4 2022 | $1,908,400 | +35.5% | 14,536 | +20.8% | 0.05% | +23.3% |
| Q3 2022 | $1,408,000 | +5.8% | 12,034 | +6.4% | 0.04% | -23.2% |
| Q2 2022 | $1,331,000 | -28.2% | 11,313 | -20.4% | 0.06% | -8.2% |
| Q1 2022 | $1,853,000 | -54.7% | 14,212 | -47.0% | 0.06% | -48.3% |
| Q4 2021 | $4,091,000 | +61.8% | 26,805 | +71.5% | 0.12% | +47.5% |
| Q3 2021 | $2,529,000 | -3.0% | 15,629 | -2.4% | 0.08% | -5.9% |
| Q2 2021 | $2,608,000 | -1.2% | 16,012 | -8.6% | 0.08% | -8.6% |
| Q1 2021 | $2,639,000 | +26.3% | 17,520 | +27.0% | 0.09% | -17.0% |
| Q4 2020 | $2,090,000 | -18.5% | 13,791 | -27.0% | 0.11% | -18.2% |
| Q3 2020 | $2,564,000 | +34.9% | 18,886 | +35.8% | 0.14% | +7.9% |
| Q2 2020 | $1,901,000 | +32.4% | 13,903 | +4.3% | 0.13% | +3.3% |
| Q1 2020 | $1,436,000 | -9.3% | 13,324 | +0.1% | 0.12% | -8.9% |
| Q4 2019 | $1,584,000 | +20.6% | 13,316 | +0.9% | 0.14% | +4.7% |
| Q3 2019 | $1,313,000 | -12.3% | 13,200 | -3.6% | 0.13% | -21.3% |
| Q2 2019 | $1,498,000 | +0.3% | 13,693 | +1.3% | 0.16% | -11.8% |
| Q1 2019 | $1,493,000 | +8.6% | 13,512 | -5.3% | 0.19% | -5.1% |
| Q4 2018 | $1,375,000 | -23.9% | 14,261 | -3.7% | 0.20% | -8.8% |
| Q3 2018 | $1,806,000 | +7.6% | 14,809 | -3.1% | 0.22% | -3.2% |
| Q2 2018 | $1,679,000 | +1.3% | 15,286 | -1.5% | 0.22% | -4.3% |
| Q1 2018 | $1,657,000 | -24.5% | 15,521 | -24.5% | 0.23% | -21.9% |
| Q4 2017 | $2,195,000 | +1.1% | 20,556 | +215.9% | 0.30% | -17.7% |
| Q3 2017 | $2,171,000 | +23.8% | 6,507 | +15.1% | 0.36% | +13.5% |
| Q2 2017 | $1,754,000 | +16.5% | 5,654 | +10.2% | 0.32% | +6.0% |
| Q1 2017 | $1,505,000 | +6.5% | 5,130 | -3.6% | 0.30% | +4.5% |
| Q4 2016 | $1,413,000 | +3.9% | 5,324 | -20.3% | 0.29% | +7.5% |
| Q3 2016 | $1,360,000 | +16.5% | 6,677 | -0.5% | 0.27% | +14.1% |
| Q2 2016 | $1,167,000 | +51.2% | 6,708 | +54.7% | 0.23% | +30.7% |
| Q1 2016 | $772,000 | -49.4% | 4,337 | -3.9% | 0.18% | -42.1% |
| Q4 2015 | $1,527,000 | +40.2% | 4,513 | +25.8% | 0.31% | +17.9% |
| Q3 2015 | $1,089,000 | -10.5% | 3,588 | +8.9% | 0.26% | -13.2% |
| Q2 2015 | $1,217,000 | -1.3% | 3,294 | -8.3% | 0.30% | +0.3% |
| Q1 2015 | $1,233,000 | -77.8% | 3,592 | -19.8% | 0.30% | +152.9% |
| Q4 2014 | $5,553,000 | +296.1% | 4,481 | -12.4% | 0.12% | -44.1% |
| Q3 2014 | $1,402,000 | -99.8% | 5,118 | +11.4% | 0.21% | +53.2% |
| Q2 2014 | $592,016,000 | +150157.9% | 4,596 | +176.0% | 0.14% | +16.8% |
| Q1 2014 | $394,000 | +25.5% | 1,665 | +20.2% | 0.12% | +19.0% |
| Q4 2013 | $314,000 | +31.9% | 1,385 | +22.0% | 0.10% | +23.5% |
| Q3 2013 | $238,000 | +22.1% | 1,135 | +1.2% | 0.08% | +22.7% |
| Q2 2013 | $195,000 | – | 1,121 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |